Clinical trial
Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance…
NCT00264797 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00264797 |
|---|---|
| Title | Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD) |
| Official title | Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD) |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH University of Colorado, Denver |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ADHD, Substance Abuse |
| Intervention type | Drug |
| Interventions | Methylphenidate (OROS-MPH), Methylphenidate (OROS-MPH) - Placebo |
| Enrollment | 303 |
| Start date | Feb 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Dec 13, 2005 |
| Last update posted | Jun 7, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: